{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:03:30Z","timestamp":1790424210941,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":704,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1002\/rth2.12461","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T20:30:46Z","timestamp":1608409846000},"page":"81-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Diagnosis and follow\u2010up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay"],"prefix":"10.1016","volume":"5","author":[{"given":"Nicolas","family":"Beranger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Benghezal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9rang\u00e8re S.","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Capdenat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Delton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Stepanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12461_bb0010","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor\u2013cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic\u2010uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12461_bb0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2352-3026(16)30018-7","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1002\/rth2.12461_bb0025","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to Von Willebrand factor\u2013cleaving protease in acute TTP","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12461_bb0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1002\/rth2.12461_bb0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.md.0000133622.03370.07","article-title":"Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement","volume":"83","author":"Coppo","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1002\/rth2.12461_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/trf.12263","article-title":"High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll\u2010like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center","volume":"54","author":"Morgand","year":"2014","journal-title":"Transfusion"},{"key":"10.1002\/rth2.12461_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy : presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0050","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw\u2010Schulman syndrome in pregnancy\u2010onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti\u2010Cohen","year":"2012","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0055","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2016-06-724161","article-title":"Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura","volume":"128","author":"Page","year":"2016","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0060","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12461_bb0070","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome: clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12461_bb0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00277-009-0877-5","article-title":"High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study","volume":"89","author":"Balduini","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1002\/rth2.12461_bb0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","article-title":"Efficacy and safety of first\u2010line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center","volume":"40","author":"Froissart","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1002\/rth2.12461_bb0085","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V124.21.229.229","article-title":"Caplacizumab, Anti\u2010VWF nanobody potentially changing the treatment paradigm in thrombotic thrombocytopenic purpura: results of the TITAN trial","volume":"124","author":"Peyvandi","year":"2014","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12461_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12461_bb0105","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factor\u2013cleaving protease in thrombotic microangiopathies: a study of 111 cases","volume":"98","author":"Veyradier","year":"2001","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti\u2010ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"key":"10.1002\/rth2.12461_bb0115","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2008.07107.x","article-title":"Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse","volume":"141","author":"Jin","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12461_bb0125","first-page":"24","article-title":"The predictive value of ADAMTS13 activity for treatment monitoring of patients with acquired TTP: data from the phase II TITAN trial with caplacizumab","volume":"13","author":"Callewaert","year":"2015","journal-title":"J Thromb haemostasis"},{"key":"10.1002\/rth2.12461_bb0130","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1538-7836.2003.00385.x","article-title":"Measurement of von Willebrand factor\u2013cleaving protease (ADAMTS\u201013) activity in plasma: a multicenter comparison of different assay methods","volume":"1","author":"Studt","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1538-7836.2010.03761.x","article-title":"ADAMTS\u201013 assays in thrombotic thrombocytopenic purpura","volume":"8","author":"Peyvandi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0140","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1538-7836.2008.03099.x","article-title":"Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS\u201013)","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0145","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2001-12-0166","article-title":"Von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"100","author":"Remuzzi","year":"2002","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0150","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor\u2013cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0155","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1055\/s-0037-1614780","article-title":"Assay of von Willebrand factor (vWF)\u2010cleaving protease based on decreased collagen binding affinity of degraded vWF. A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)","volume":"82","author":"Gerritsen","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0160","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00277-002-0502-3","article-title":"Evaluation and clinical application of a new method for measuring activity of von Willebrand factor\u2013cleaving metalloprotease (ADAMTS13)","volume":"81","author":"B\u00f6hm","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1002\/rth2.12461_bb0165","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1055\/s-0037-1614779","article-title":"Estimation of the von Willebrand factor\u2013cleaving protease in plasma using monoclonal antibodies to vWF","volume":"82","author":"Obert","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0170","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.thromres.2014.09.006","article-title":"Evaluation of a chromogenic commercial assay using VWF\u201073 peptide for ADAMTS13 activity measurement","volume":"134","author":"Joly","year":"2014","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12461_bb0175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH12-08-0565","article-title":"Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies","volume":"109","author":"Mackie","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0180","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1160\/TH13-05-0393","article-title":"Evaluation of a commercial assay for ADAMTS13 activity measurement","volume":"110","author":"Thouzeau","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1538-7836.2006.01758.x","article-title":"A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption\/ionization time\u2010of\u2010flight (SELDI\u2010TOF)\u2010mass spectrometry","volume":"4","author":"Jin","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS\u2010VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12461_bb0195","first-page":"1297","article-title":"Highly sensitive fully automated chemiluminescent immunoassay for rapid quantification of ADAMTS13 activity","volume":"1","author":"Mirabet","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0200","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody\u2010based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"key":"10.1002\/rth2.12461_bb0205","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1055\/s-0039-1696718","article-title":"Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity","volume":"119","author":"Valsecchi","year":"2019","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1002\/rth2.12461_bb0210","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s11239-020-02086-8","article-title":"Evaluation of a rapid turn\u2010over, fully\u2010automated ADAMTS13 activity assay: a method comparison study","volume":"50","author":"Stratmann","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1002\/rth2.12461_bb0215","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0038-1641151","article-title":"Evaluation of the fully automated HemosIL Acustar ADAMTS13 Activity assay","volume":"118","author":"Favresse","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0220","first-page":"1","article-title":"The French Reference Center for Thrombotic Microangiopathies. Child\u2010onset and adolescent\u2010onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency : a cohort study of the French national registry for thrombotic microangiopathy","volume":"3026","author":"Joly","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1002\/rth2.12461_bb0225","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jth.12881","article-title":"Establishment of the WHO 1st International Standard ADAMTS13, plasma (12\/252): Communication from the SSC of the ISTH","volume":"13","author":"Hubbard","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0230","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/jth.12901","article-title":"Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease","volume":"13","author":"Lu","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12461_bb0235","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","article-title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency\u2010associated idiopathic thrombotic thrombocytopenic purpura: The French TMA Reference Center experience","volume":"97","author":"Benhamou","year":"2012","journal-title":"Haematologica"},{"key":"10.1002\/rth2.12461_bb0240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V124.21.231.231","article-title":"Derivation and prospective validation of a predictive score for the rapid diagnosis of thrombotic thrombocytopenic purpura: the Plasmic score","volume":"124","author":"Bendapudi","year":"2014","journal-title":"Blood"},{"key":"10.1002\/rth2.12461_bb0245","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/trf.13359","article-title":"Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura","volume":"56","author":"Connell","year":"2016","journal-title":"Transfusion"},{"key":"10.1002\/rth2.12461_bb0250","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2004-03-1101","article-title":"Proteolytic inactivation of ADAMTS13 by thrombin and plasmin","volume":"105","author":"Crawley","year":"2005","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12461","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922013127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922013127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:22:46Z","timestamp":1762863766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922013127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2475037922013127"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12461","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and follow\u2010up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}